Literature DB >> 30353790

Living Well: An Intervention to Improve Medical Illness Self-Management Among Individuals With Serious Mental Illness.

Anjana Muralidharan1, Clayton H Brown1, Jason E Peer1, Elizabeth A Klingaman1, Samantha M Hack1, Lan Li1, Mary Brighid Walsh1, Richard W Goldberg1.   

Abstract

OBJECTIVE: Many adults with serious mental illness have significant medical illness burden and poor illness self-management. In this study, the authors examined Living Well, a group-based illness self-management intervention for adults with serious mental illness that was cofacilitated by two providers, one of whom has lived experience with co-occurring mental health and medical conditions.
METHODS: Adults with serious mental illness (N=242) were randomly assigned to Living Well or an active control condition. Participants completed assessments of quality of life; health attitudes; self-management behaviors; and symptoms at baseline, posttreatment, and follow-up. Emergency room use was assessed by means of chart review. Mixed-effects models examined group × time interactions on outcomes.
RESULTS: Compared with the control group, adults in Living Well had greater improvements at posttreatment in mental health-related quality of life (t=2.15, p=.032), self-management self-efficacy (t=4.10, p<.001), patient activation (t=2.08, p=.038), internal health locus of control (t=2.01, p=.045), behavioral and cognitive symptom management (t=2.77, p=.006), and overall psychiatric symptoms (t=-2.02, p=.044); they had greater improvements at follow-up in physical activity-related self-management (t=2.55, p=.011) and relationship quality (t=-2.45, p=.015). No effects were found for emergency room use. The control group exhibited greater increases in physical health-related quality of life at posttreatment (t=-2.23, p=.026). Significant group differences in self-management self-efficacy (t=2.86,p=.004) and behavioral and cognitive symptom management (t=2.08, p= .038) were maintained at follow-up.
CONCLUSIONS: Compared with an active control group, a peer-cofacilitated illness self-management group was more effective in improving quality of life and self-management self-efficacy among adults with serious mental illness.

Entities:  

Keywords:  health and wellness; illness self-management; peer-delivered intervention; serious mental illness

Mesh:

Year:  2018        PMID: 30353790      PMCID: PMC6494087          DOI: 10.1176/appi.ps.201800162

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  23 in total

1.  A Peer- and Technology-Supported Self-Management Intervention.

Authors:  Karen L Whiteman; Matthew C Lohman; Stephen J Bartels
Journal:  Psychiatr Serv       Date:  2017-04-01       Impact factor: 3.084

2.  The Role of Peers in Health Interventions for Serious Mental Illness.

Authors:  Kelly A Aschbrenner; Mary F Brunette
Journal:  Psychiatr Serv       Date:  2018-05-01       Impact factor: 3.084

3.  Meta-analysis: chronic disease self-management programs for older adults.

Authors:  Joshua Chodosh; Sally C Morton; Walter Mojica; Margaret Maglione; Marika J Suttorp; Lara Hilton; Shannon Rhodes; Paul Shekelle
Journal:  Ann Intern Med       Date:  2005-09-20       Impact factor: 25.391

4.  Effectiveness of the chronic disease self-management program for persons with a serious mental illness: a translation study.

Authors:  Kate Lorig; Philip L Ritter; Carolyn Pifer; Pamela Werner
Journal:  Community Ment Health J       Date:  2013-06-08

5.  Are patients at Veterans Affairs medical centers sicker? A comparative analysis of health status and medical resource use.

Authors:  Z Agha; R P Lofgren; J V VanRuiswyk; P M Layde
Journal:  Arch Intern Med       Date:  2000-11-27

6.  Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers.

Authors:  Judith H Hibbard; Jean Stockard; Eldon R Mahoney; Martin Tusler
Journal:  Health Serv Res       Date:  2004-08       Impact factor: 3.402

7.  Peer-Led Self-Management of General Medical Conditions for Patients With Serious Mental Illnesses: A Randomized Trial.

Authors:  Benjamin G Druss; Manasvini Singh; Silke A von Esenwein; Gretl E Glick; Stephanie Tapscott; Sherry Jenkins Tucker; Cathy A Lally; Evelina W Sterling
Journal:  Psychiatr Serv       Date:  2018-02-01       Impact factor: 3.084

8.  Psychometric properties of the BASIS-24© (Behaviour and Symptom Identification Scale-Revised) Mental Health Outcome Measure.

Authors:  I M Cameron; L Cunningham; J R Crawford; J M Eagles; S V Eisen; K Lawton; S A Naji; R J Hamilton
Journal:  Int J Psychiatry Clin Pract       Date:  2007       Impact factor: 1.812

9.  Premature Mortality Among Adults With Schizophrenia in the United States.

Authors:  Mark Olfson; Tobias Gerhard; Cecilia Huang; Stephen Crystal; T Scott Stroup
Journal:  JAMA Psychiatry       Date:  2015-12       Impact factor: 21.596

10.  Ethnicity and excess mortality in severe mental illness: a cohort study.

Authors:  Jayati Das-Munshi; Chin-Kuo Chang; Rina Dutta; Craig Morgan; James Nazroo; Robert Stewart; Martin J Prince
Journal:  Lancet Psychiatry       Date:  2017-03-16       Impact factor: 27.083

View more
  3 in total

1.  Health Behavior Change Processes Among Adults With Serious Mental Illness Engaged in Illness Self-Management.

Authors:  Anjana Muralidharan; Amanda Peeples; Alicia Lucksted
Journal:  Qual Health Res       Date:  2021-02-15

2.  Predictors of attendance in health and wellness treatment groups for people with serious mental illness.

Authors:  Peter L Phalen; Anjana Muralidharan; Letitia Travaglini; Melanie Bennett; Naomi Stahl; Clayton Brown; Samantha Hack; Elizabeth A Klingaman; Richard Goldberg
Journal:  Psychiatr Rehabil J       Date:  2019-07-01

3.  Participant Experiences With a Peer-Led Healthy Lifestyle Intervention for People With Serious Mental Illness.

Authors:  Ana Stefancic; Lauren Bochicchio; Daniela Tuda; Kristen Gurdak; Leopoldo J Cabassa
Journal:  Psychiatr Serv       Date:  2021-03-04       Impact factor: 3.084

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.